Chris Schelling's most recent trade in Acer Therapeutics Inc was a trade of 819,672 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on Nov. 29, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acer Therapeutics Inc | Chris Schelling | Director, President & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 29 Nov 2022 | 819,672 | 2,712,529 (26%) | 8% | 1.2 | 1,000,000 | Common Stock |
| Acer Therapeutics Inc | Chris Schelling | Director, President & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Acer Therapeutics Inc | Chris Schelling | Director, President & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |